Virtus Biotech Clinical Trials ETF BBC
44.99 USD +1.97 (+4.58%)
Nov 9, 2026, 3:57 PM EST
44.12 Day range 45.39
30.47 52-week range 56.18
- YTD
- +16.68%
- 1 year
- +51.53%
Benzinga news
benzinga.com Healthcare ETFs Trounce Tech, Grab Billions As Big Money Flees Bubble Fears Healthcare ETFs are raking in fresh inflows while tech bleeds, reflecting a defensive shift as investors grow wary of frothy valuations.
benzinga.com Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation FDA names Vinay Prasad to lead CBER, raising questions over biologics oversight and triggering biotech stock losses and analyst concerns.